Results 201 to 210 of about 46,339 (291)

N-terminal pro-brain natriuretic peptide: a potential follow-up biomarker of mandibular advancement device efficacy on cardiac function in obstructive sleep apnea [PDF]

, 2018
Denis Monneret
openalex   +1 more source

Risk Factors Associated With Sarcopenia in Patients With Chronic Kidney Disease: A Systematic Review and Meta‐Analysis

Journal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 1, February 2026.
ABSTRACT Background Sarcopenia is an age‐related degenerative disorder characterized by a progressive decline in skeletal muscle mass, strength, and function with high prevalence in chronic kidney disease (CKD). Identifying clinical and epidemiological factors of sarcopenia in patients with CKD is essential to enable early recognition and appropriate ...
Kaili Jin, Xiaoyan Li, Yiqin Ma, Dan Yang, Xiaoxue Tan, Qiuhua Sun, Rongyun Wang   +6 more
wiley   +1 more source

Evaluation of a Point-of-Care N-Terminal Pro-Brain Natriuretic Peptide Assay for Heart Failure Management. [PDF]

Cardiol Res
Belik F, Benamour M, Laffalize A, Lavalleye T, Van Belle L, Pouleur AC, Gruson D.   +6 more
europepmc   +1 more source

Mitral Regurgitation and Serum N-Terminal Pro-Brain Natriuretic Peptide Levels in Children: A Modification of Adult Criteria. [PDF]

Tex Heart Inst J, 2022
Erolu E, Akalin F.
europepmc   +1 more source

Catheter Ablation and Device Therapy in Patients With Transthyretin Amyloid Cardiomyopathy: A Review of Non‐Pharmacological Therapy

Journal of Arrhythmia, Volume 42, Issue 1, February 2026.
Transthyretin cardiomyopathy (ATTR‐CM) frequently coexists with atrial fibrillation, atrial flutter, and atrial tachycardia as well as occasionally ventricular arrhythmias and often conduction abnormalities, necessitating management for arrhythmias. Therefore, for arrhythmia specialists, the ability to diagnose ATTR‐CM and proficiency in arrhythmia ...
Hisanori Kanazawa, Tadashi Hoshiyama, Shozo Kaneko, Yusei Kawahara, Yuichiro Tsuruta, Yuta Tsurusaki, Kohei Matsunaga, Shunsuke Tamanoi, Naoto Kuyama, Hiroki Usuku, Eiichiro Yamamoto, Yasuhiro Izumiya, Kenichi Tsujita   +12 more
wiley   +1 more source

N-terminal pro-brain natriuretic peptide as a predictor of postoperative atrial fibrillation in off-pump coronary artery bypass grafting patients. [PDF]

BMC Cardiovasc Disord
Li X, Shen Z, Qi Y, Chu M, Wu M, Feng C, Liu Z, Wang Y, Zhang J, Lu X, Lu P.   +10 more
europepmc   +1 more source

Prediction of Heart Function and Volume Status in End-Stage Kidney Disease Patients through N-Terminal Pro-Brain Natriuretic Peptide. [PDF]

Medicina (Kaunas), 2022
Lee KH, Moon I, Oh YS, Yu BC, Park MY, Kim JK, Choi SJ.   +6 more
europepmc   +1 more source

Impact of Lipid Profile Alterations on the Right Heart Function and Prognosis in Pre‐Capillary Pulmonary Hypertension Patients: A Prospective Cohort Study

Respirology, Volume 31, Issue 2, Page 174-183, February 2026.
This study found that reduced HDL‐C correlates with impaired RV systolic function and RA strain, highlighting a mechanistic link between lipid abnormalities and right heart remodelling. Additionally, decreased HDL‐C and LDL‐C were identified as independent mortality predictors in precPH patients. Integrating lipid parameters into ESC and ESC‐CMR models
Jiajun Guo, Ji Zhao, Jiaqi Wang, Yangjie Li, Juan He, Chen Chen, Xuhan Liu, Lidan Yin, Shoufang Pu, Bi Wen, Min Luo, Yuanwei Xu, Ke Wan, Yuchi Han, Yucheng Chen   +14 more
wiley   +1 more source

Correlation between 25-hydroxyvitamin D, N-terminal pro-brain natriuretic peptide, inflammatory factors and myocardial injury in children with mycoplasma pneumoniae pneumonia. [PDF]

BMC Pediatr
Liu Y, Li P.
europepmc   +1 more source

Value of N-Terminal Pro-Brain Natriuretic Peptide for Embolic Events Risk Prediction in Patients with Atrial Fibrillation; a Systematic Review and Meta-Analysis. [PDF]

Arch Acad Emerg Med, 2023
Ahmadzadeh K, Hajebi A, Adel Ramawad H, Azizi Y, Yousefifard M.   +4 more
europepmc   +1 more source